Patient demographics
| Characteristic . | Dose . | ||||
|---|---|---|---|---|---|
| 2 mg/kg, n = 6 . | 4 mg/kg, n = 6 . | 8 mg/kg, n = 6 . | 12 mg/kg, n = 6 . | Total, n = 24 . | |
| Mean age, y | 34.5 | 40.8 | 40.0 | 41.2 | 39.1 |
| Sex, M/F | 4/2 | 4/2 | 2/4 | 1/5 | 11/13 |
| Primary diagnosis | |||||
| HD | 5 | 5 | 5 | 6 | 21 |
| NHL | 1 | 1 | 1 | 0 | 3 |
| Mean interval since diagnosis, y | 3.4 | 6.8 | 5.7 | 3.9 | 5.0 |
| Prior surgery | 0 | 3 | 2 | 1 | 6 |
| Prior radiotherapy | 4 | 5 | 6 | 5 | 20 |
| Prior transplantation | 6 | 5 | 5 | 4 | 20 |
| Prior chemotherapy regimens | |||||
| 2 to 4 | 2 | 1 | 1 | 3 | 7 |
| 5 to 7 | 3 | 3 | 2 | 3 | 11 |
| 8 to 10 | 1 | 2 | 3 | 0 | 6 |
| Characteristic . | Dose . | ||||
|---|---|---|---|---|---|
| 2 mg/kg, n = 6 . | 4 mg/kg, n = 6 . | 8 mg/kg, n = 6 . | 12 mg/kg, n = 6 . | Total, n = 24 . | |
| Mean age, y | 34.5 | 40.8 | 40.0 | 41.2 | 39.1 |
| Sex, M/F | 4/2 | 4/2 | 2/4 | 1/5 | 11/13 |
| Primary diagnosis | |||||
| HD | 5 | 5 | 5 | 6 | 21 |
| NHL | 1 | 1 | 1 | 0 | 3 |
| Mean interval since diagnosis, y | 3.4 | 6.8 | 5.7 | 3.9 | 5.0 |
| Prior surgery | 0 | 3 | 2 | 1 | 6 |
| Prior radiotherapy | 4 | 5 | 6 | 5 | 20 |
| Prior transplantation | 6 | 5 | 5 | 4 | 20 |
| Prior chemotherapy regimens | |||||
| 2 to 4 | 2 | 1 | 1 | 3 | 7 |
| 5 to 7 | 3 | 3 | 2 | 3 | 11 |
| 8 to 10 | 1 | 2 | 3 | 0 | 6 |